Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Paulus

Showing results (11-20 of 244) with videos related to

Pageof 25
Sort By:
Arthritis and Rheumatism|November 1, 1983
Government affairs. FDA Arthritis Advisory Committee MeetingH E Paulus
Arthritis and Rheumatism|October 1, 1986
FDA Arthritis Advisory Committee meeting: methotrexate; guidelines for the clinical evaluation of antiinflammatory drugs; DMSO in sclerodermaH E Paulus
Annals of the Rheumatic Diseases|January 1, 1982
An overview of benefit/risk of disease modifying treatment of rheumatoid arthritis as of todayH E Paulus
The Journal of Rheumatology. Supplement|October 1, 1994
Outcome measures in rheumatoid arthritis. IntroductionH E Paulus
Arthritis and Rheumatism|July 1, 1992
FDA Arthritis Advisory Committee meeting: guidelines for clinical evaluation of therapies for sclerodermaH E Paulus
The American Journal of Medicine|October 14, 1988
Antimalarial agents compared with or in combination with other disease-modifying antirheumatic drugsH E Paulus
Arthritis and Rheumatism|July 1, 1990
FDA Arthritis Advisory Committee meeting: guidelines for approving nonsteroidal antiinflammatory drugs for over-the-counter useH E Paulus
Arthritis and Rheumatism|September 1, 1982
FDA Arthritis Advisory Committee meetingH E Paulus
Arthritis and Rheumatism|October 1, 1985
FDA Arthritis Advisory Committee meeting: postmarketing surveillance of nonsteroidal antiinflammatory drugsH E Paulus
Arthritis and Rheumatism|October 1, 1983
FDA Arthritis Advisory Committee MeetingH E Paulus
Pageof 25

Showing results (11-20 of 244) with videos related to

Sort By:
Pageof 25
Arthritis and Rheumatism|November 1, 1983
Government affairs. FDA Arthritis Advisory Committee MeetingH E Paulus
Arthritis and Rheumatism|October 1, 1986
FDA Arthritis Advisory Committee meeting: methotrexate; guidelines for the clinical evaluation of antiinflammatory drugs; DMSO in sclerodermaH E Paulus
Annals of the Rheumatic Diseases|January 1, 1982
An overview of benefit/risk of disease modifying treatment of rheumatoid arthritis as of todayH E Paulus
The Journal of Rheumatology. Supplement|October 1, 1994
Outcome measures in rheumatoid arthritis. IntroductionH E Paulus
Arthritis and Rheumatism|July 1, 1992
FDA Arthritis Advisory Committee meeting: guidelines for clinical evaluation of therapies for sclerodermaH E Paulus
The American Journal of Medicine|October 14, 1988
Antimalarial agents compared with or in combination with other disease-modifying antirheumatic drugsH E Paulus
Arthritis and Rheumatism|July 1, 1990
FDA Arthritis Advisory Committee meeting: guidelines for approving nonsteroidal antiinflammatory drugs for over-the-counter useH E Paulus
Arthritis and Rheumatism|September 1, 1982
FDA Arthritis Advisory Committee meetingH E Paulus
Arthritis and Rheumatism|October 1, 1985
FDA Arthritis Advisory Committee meeting: postmarketing surveillance of nonsteroidal antiinflammatory drugsH E Paulus
Arthritis and Rheumatism|October 1, 1983
FDA Arthritis Advisory Committee MeetingH E Paulus
Pageof 25